Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples